SENS•globenewswire•
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
Summary
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2025 Healthcare Conference, being held in New York, NY.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 10, 2025 by globenewswire